Efficacy and Safety of Iloperidone in Bipolar Mania Article Swipe
Rosarelis Torres
,
Emily L. Czeisler
,
Sean R. Chadwick
,
Stephen M. Stahl
,
Sandra Smieszek
,
Changfu Xiao
,
Christos Polymeropoulos
,
Gunther Birznieks
,
Mihael H. Polymeropoulos
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.4088/jcp.23m14966
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.4088/jcp.23m14966
Trial Registration: ClinicalTrials.gov identifier: NCT04819776; EudraCT: 2020-000405-83.
Related Topics
Concepts
Young Mania Rating Scale
Mania
Tolerability
Placebo
Bipolar disorder
Internal medicine
Positive and Negative Syndrome Scale
Psychology
Clinical endpoint
Bipolar I disorder
Adverse effect
Extrapyramidal symptoms
Psychiatry
Clinical Global Impression
Medicine
Randomized controlled trial
Antipsychotic
Schizophrenia (object-oriented programming)
Psychosis
Mood
Alternative medicine
Pathology
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.4088/jcp.23m14966
- https://www.psychiatrist.com/read-pdf/51087
- OA Status
- bronze
- Cited By
- 6
- References
- 55
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4390788642
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4390788642Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.4088/jcp.23m14966Digital Object Identifier
- Title
-
Efficacy and Safety of Iloperidone in Bipolar ManiaWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-01-12Full publication date if available
- Authors
-
Rosarelis Torres, Emily L. Czeisler, Sean R. Chadwick, Stephen M. Stahl, Sandra Smieszek, Changfu Xiao, Christos Polymeropoulos, Gunther Birznieks, Mihael H. PolymeropoulosList of authors in order
- Landing page
-
https://doi.org/10.4088/jcp.23m14966Publisher landing page
- PDF URL
-
https://www.psychiatrist.com/read-pdf/51087Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
bronzeOpen access status per OpenAlex
- OA URL
-
https://www.psychiatrist.com/read-pdf/51087Direct OA link when available
- Concepts
-
Young Mania Rating Scale, Mania, Tolerability, Placebo, Bipolar disorder, Internal medicine, Positive and Negative Syndrome Scale, Psychology, Clinical endpoint, Bipolar I disorder, Adverse effect, Extrapyramidal symptoms, Psychiatry, Clinical Global Impression, Medicine, Randomized controlled trial, Antipsychotic, Schizophrenia (object-oriented programming), Psychosis, Mood, Alternative medicine, PathologyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
6Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 5, 2024: 1Per-year citation counts (last 5 years)
- References (count)
-
55Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4390788642 |
|---|---|
| doi | https://doi.org/10.4088/jcp.23m14966 |
| ids.doi | https://doi.org/10.4088/jcp.23m14966 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/38236020 |
| ids.openalex | https://openalex.org/W4390788642 |
| fwci | 5.37725841 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D000328 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Adult |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D006801 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Humans |
| mesh[2].qualifier_ui | Q000175 |
| mesh[2].descriptor_ui | D001714 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | diagnosis |
| mesh[2].descriptor_name | Bipolar Disorder |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D000087122 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | Mania |
| mesh[4].qualifier_ui | |
| mesh[4].descriptor_ui | D016896 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | |
| mesh[4].descriptor_name | Treatment Outcome |
| mesh[5].qualifier_ui | Q000009 |
| mesh[5].descriptor_ui | D014150 |
| mesh[5].is_major_topic | True |
| mesh[5].qualifier_name | adverse effects |
| mesh[5].descriptor_name | Antipsychotic Agents |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D004311 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Double-Blind Method |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D011569 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Psychiatric Status Rating Scales |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D007555 |
| mesh[8].is_major_topic | True |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Isoxazoles |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D010880 |
| mesh[9].is_major_topic | True |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Piperidines |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D000328 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Adult |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D006801 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Humans |
| mesh[12].qualifier_ui | Q000175 |
| mesh[12].descriptor_ui | D001714 |
| mesh[12].is_major_topic | True |
| mesh[12].qualifier_name | diagnosis |
| mesh[12].descriptor_name | Bipolar Disorder |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D000087122 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Mania |
| mesh[14].qualifier_ui | |
| mesh[14].descriptor_ui | D016896 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | |
| mesh[14].descriptor_name | Treatment Outcome |
| mesh[15].qualifier_ui | Q000009 |
| mesh[15].descriptor_ui | D014150 |
| mesh[15].is_major_topic | True |
| mesh[15].qualifier_name | adverse effects |
| mesh[15].descriptor_name | Antipsychotic Agents |
| mesh[16].qualifier_ui | |
| mesh[16].descriptor_ui | D004311 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | |
| mesh[16].descriptor_name | Double-Blind Method |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D011569 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Psychiatric Status Rating Scales |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D007555 |
| mesh[18].is_major_topic | True |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Isoxazoles |
| mesh[19].qualifier_ui | |
| mesh[19].descriptor_ui | D010880 |
| mesh[19].is_major_topic | True |
| mesh[19].qualifier_name | |
| mesh[19].descriptor_name | Piperidines |
| type | article |
| title | Efficacy and Safety of Iloperidone in Bipolar Mania |
| biblio.issue | 1 |
| biblio.volume | 85 |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T10854 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9997000098228455 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2738 |
| topics[0].subfield.display_name | Psychiatry and Mental health |
| topics[0].display_name | Bipolar Disorder and Treatment |
| topics[1].id | https://openalex.org/T12547 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9686999917030334 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2735 |
| topics[1].subfield.display_name | Pediatrics, Perinatology and Child Health |
| topics[1].display_name | Pharmaceutical studies and practices |
| topics[2].id | https://openalex.org/T10023 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9340000152587891 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2738 |
| topics[2].subfield.display_name | Psychiatry and Mental health |
| topics[2].display_name | Schizophrenia research and treatment |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2777089681 |
| concepts[0].level | 5 |
| concepts[0].score | 0.9031716585159302 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q4340609 |
| concepts[0].display_name | Young Mania Rating Scale |
| concepts[1].id | https://openalex.org/C2776809841 |
| concepts[1].level | 4 |
| concepts[1].score | 0.7808662056922913 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q185935 |
| concepts[1].display_name | Mania |
| concepts[2].id | https://openalex.org/C2778375690 |
| concepts[2].level | 3 |
| concepts[2].score | 0.6819940805435181 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q7814214 |
| concepts[2].display_name | Tolerability |
| concepts[3].id | https://openalex.org/C27081682 |
| concepts[3].level | 3 |
| concepts[3].score | 0.6559109091758728 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q269829 |
| concepts[3].display_name | Placebo |
| concepts[4].id | https://openalex.org/C2776174506 |
| concepts[4].level | 3 |
| concepts[4].score | 0.5933529734611511 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q131755 |
| concepts[4].display_name | Bipolar disorder |
| concepts[5].id | https://openalex.org/C126322002 |
| concepts[5].level | 1 |
| concepts[5].score | 0.5468584299087524 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[5].display_name | Internal medicine |
| concepts[6].id | https://openalex.org/C2780135775 |
| concepts[6].level | 3 |
| concepts[6].score | 0.5251873731613159 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q7233251 |
| concepts[6].display_name | Positive and Negative Syndrome Scale |
| concepts[7].id | https://openalex.org/C15744967 |
| concepts[7].level | 0 |
| concepts[7].score | 0.5088167786598206 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q9418 |
| concepts[7].display_name | Psychology |
| concepts[8].id | https://openalex.org/C203092338 |
| concepts[8].level | 3 |
| concepts[8].score | 0.49393612146377563 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q1340863 |
| concepts[8].display_name | Clinical endpoint |
| concepts[9].id | https://openalex.org/C2778609679 |
| concepts[9].level | 5 |
| concepts[9].score | 0.4561956524848938 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q4915474 |
| concepts[9].display_name | Bipolar I disorder |
| concepts[10].id | https://openalex.org/C197934379 |
| concepts[10].level | 2 |
| concepts[10].score | 0.45078766345977783 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q2047938 |
| concepts[10].display_name | Adverse effect |
| concepts[11].id | https://openalex.org/C2780616385 |
| concepts[11].level | 4 |
| concepts[11].score | 0.4307178258895874 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q1385411 |
| concepts[11].display_name | Extrapyramidal symptoms |
| concepts[12].id | https://openalex.org/C118552586 |
| concepts[12].level | 1 |
| concepts[12].score | 0.4219886064529419 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q7867 |
| concepts[12].display_name | Psychiatry |
| concepts[13].id | https://openalex.org/C2776000289 |
| concepts[13].level | 4 |
| concepts[13].score | 0.42179161310195923 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q5133761 |
| concepts[13].display_name | Clinical Global Impression |
| concepts[14].id | https://openalex.org/C71924100 |
| concepts[14].level | 0 |
| concepts[14].score | 0.4193156361579895 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[14].display_name | Medicine |
| concepts[15].id | https://openalex.org/C168563851 |
| concepts[15].level | 2 |
| concepts[15].score | 0.3925066888332367 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q1436668 |
| concepts[15].display_name | Randomized controlled trial |
| concepts[16].id | https://openalex.org/C2780494398 |
| concepts[16].level | 3 |
| concepts[16].score | 0.3373284637928009 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q208144 |
| concepts[16].display_name | Antipsychotic |
| concepts[17].id | https://openalex.org/C2776412080 |
| concepts[17].level | 2 |
| concepts[17].score | 0.18997883796691895 |
| concepts[17].wikidata | https://www.wikidata.org/wiki/Q7431605 |
| concepts[17].display_name | Schizophrenia (object-oriented programming) |
| concepts[18].id | https://openalex.org/C2779727114 |
| concepts[18].level | 2 |
| concepts[18].score | 0.16771021485328674 |
| concepts[18].wikidata | https://www.wikidata.org/wiki/Q170082 |
| concepts[18].display_name | Psychosis |
| concepts[19].id | https://openalex.org/C2780733359 |
| concepts[19].level | 2 |
| concepts[19].score | 0.14316916465759277 |
| concepts[19].wikidata | https://www.wikidata.org/wiki/Q331769 |
| concepts[19].display_name | Mood |
| concepts[20].id | https://openalex.org/C204787440 |
| concepts[20].level | 2 |
| concepts[20].score | 0.0 |
| concepts[20].wikidata | https://www.wikidata.org/wiki/Q188504 |
| concepts[20].display_name | Alternative medicine |
| concepts[21].id | https://openalex.org/C142724271 |
| concepts[21].level | 1 |
| concepts[21].score | 0.0 |
| concepts[21].wikidata | https://www.wikidata.org/wiki/Q7208 |
| concepts[21].display_name | Pathology |
| keywords[0].id | https://openalex.org/keywords/young-mania-rating-scale |
| keywords[0].score | 0.9031716585159302 |
| keywords[0].display_name | Young Mania Rating Scale |
| keywords[1].id | https://openalex.org/keywords/mania |
| keywords[1].score | 0.7808662056922913 |
| keywords[1].display_name | Mania |
| keywords[2].id | https://openalex.org/keywords/tolerability |
| keywords[2].score | 0.6819940805435181 |
| keywords[2].display_name | Tolerability |
| keywords[3].id | https://openalex.org/keywords/placebo |
| keywords[3].score | 0.6559109091758728 |
| keywords[3].display_name | Placebo |
| keywords[4].id | https://openalex.org/keywords/bipolar-disorder |
| keywords[4].score | 0.5933529734611511 |
| keywords[4].display_name | Bipolar disorder |
| keywords[5].id | https://openalex.org/keywords/internal-medicine |
| keywords[5].score | 0.5468584299087524 |
| keywords[5].display_name | Internal medicine |
| keywords[6].id | https://openalex.org/keywords/positive-and-negative-syndrome-scale |
| keywords[6].score | 0.5251873731613159 |
| keywords[6].display_name | Positive and Negative Syndrome Scale |
| keywords[7].id | https://openalex.org/keywords/psychology |
| keywords[7].score | 0.5088167786598206 |
| keywords[7].display_name | Psychology |
| keywords[8].id | https://openalex.org/keywords/clinical-endpoint |
| keywords[8].score | 0.49393612146377563 |
| keywords[8].display_name | Clinical endpoint |
| keywords[9].id | https://openalex.org/keywords/bipolar-i-disorder |
| keywords[9].score | 0.4561956524848938 |
| keywords[9].display_name | Bipolar I disorder |
| keywords[10].id | https://openalex.org/keywords/adverse-effect |
| keywords[10].score | 0.45078766345977783 |
| keywords[10].display_name | Adverse effect |
| keywords[11].id | https://openalex.org/keywords/extrapyramidal-symptoms |
| keywords[11].score | 0.4307178258895874 |
| keywords[11].display_name | Extrapyramidal symptoms |
| keywords[12].id | https://openalex.org/keywords/psychiatry |
| keywords[12].score | 0.4219886064529419 |
| keywords[12].display_name | Psychiatry |
| keywords[13].id | https://openalex.org/keywords/clinical-global-impression |
| keywords[13].score | 0.42179161310195923 |
| keywords[13].display_name | Clinical Global Impression |
| keywords[14].id | https://openalex.org/keywords/medicine |
| keywords[14].score | 0.4193156361579895 |
| keywords[14].display_name | Medicine |
| keywords[15].id | https://openalex.org/keywords/randomized-controlled-trial |
| keywords[15].score | 0.3925066888332367 |
| keywords[15].display_name | Randomized controlled trial |
| keywords[16].id | https://openalex.org/keywords/antipsychotic |
| keywords[16].score | 0.3373284637928009 |
| keywords[16].display_name | Antipsychotic |
| keywords[17].id | https://openalex.org/keywords/schizophrenia |
| keywords[17].score | 0.18997883796691895 |
| keywords[17].display_name | Schizophrenia (object-oriented programming) |
| keywords[18].id | https://openalex.org/keywords/psychosis |
| keywords[18].score | 0.16771021485328674 |
| keywords[18].display_name | Psychosis |
| keywords[19].id | https://openalex.org/keywords/mood |
| keywords[19].score | 0.14316916465759277 |
| keywords[19].display_name | Mood |
| language | en |
| locations[0].id | doi:10.4088/jcp.23m14966 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S17992710 |
| locations[0].source.issn | 0160-6689, 1534-8628, 1555-2101 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0160-6689 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | The Journal of Clinical Psychiatry |
| locations[0].source.host_organization | https://openalex.org/P4322614534 |
| locations[0].source.host_organization_name | Physicians Postgraduate Press, Inc. |
| locations[0].source.host_organization_lineage | https://openalex.org/P4322614534 |
| locations[0].source.host_organization_lineage_names | Physicians Postgraduate Press, Inc. |
| locations[0].license | |
| locations[0].pdf_url | https://www.psychiatrist.com/read-pdf/51087 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | The Journal of Clinical Psychiatry |
| locations[0].landing_page_url | https://doi.org/10.4088/jcp.23m14966 |
| locations[1].id | pmid:38236020 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | The Journal of clinical psychiatry |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/38236020 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5067769472 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Rosarelis Torres |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210126775 |
| authorships[0].affiliations[0].raw_affiliation_string | Vanda Pharmaceuticals, Inc, Washington, DC. |
| authorships[0].affiliations[1].raw_affiliation_string | Rosarelis Torres, PhD, 2200 Pennsylvania NW, Suite 300-E, Washington, DC 20037 ([email protected]). |
| authorships[0].institutions[0].id | https://openalex.org/I4210126775 |
| authorships[0].institutions[0].ror | https://ror.org/0394qmm90 |
| authorships[0].institutions[0].type | company |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210126775 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | Vanda Pharmaceuticals (United States) |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Rosarelis Torres |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Rosarelis Torres, PhD, 2200 Pennsylvania NW, Suite 300-E, Washington, DC 20037 ([email protected])., Vanda Pharmaceuticals, Inc, Washington, DC. |
| authorships[1].author.id | https://openalex.org/A5057787297 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Emily L. Czeisler |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210126775 |
| authorships[1].affiliations[0].raw_affiliation_string | Vanda Pharmaceuticals, Inc, Washington, DC. |
| authorships[1].institutions[0].id | https://openalex.org/I4210126775 |
| authorships[1].institutions[0].ror | https://ror.org/0394qmm90 |
| authorships[1].institutions[0].type | company |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210126775 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | Vanda Pharmaceuticals (United States) |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Emily L Czeisler |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Vanda Pharmaceuticals, Inc, Washington, DC. |
| authorships[2].author.id | https://openalex.org/A5014493918 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-2424-7983 |
| authorships[2].author.display_name | Sean R. Chadwick |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210126775 |
| authorships[2].affiliations[0].raw_affiliation_string | Vanda Pharmaceuticals, Inc, Washington, DC. |
| authorships[2].institutions[0].id | https://openalex.org/I4210126775 |
| authorships[2].institutions[0].ror | https://ror.org/0394qmm90 |
| authorships[2].institutions[0].type | company |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210126775 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | Vanda Pharmaceuticals (United States) |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Sean R Chadwick |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Vanda Pharmaceuticals, Inc, Washington, DC. |
| authorships[3].author.id | https://openalex.org/A5015501263 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-6536-6973 |
| authorships[3].author.display_name | Stephen M. Stahl |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I36258959 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Psychiatry, University of California, San Diego. |
| authorships[3].institutions[0].id | https://openalex.org/I36258959 |
| authorships[3].institutions[0].ror | https://ror.org/0168r3w48 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I36258959 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | University of California, San Diego |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Stephen M Stahl |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Psychiatry, University of California, San Diego. |
| authorships[4].author.id | https://openalex.org/A5079657055 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-8006-0454 |
| authorships[4].author.display_name | Sandra Smieszek |
| authorships[4].countries | US |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210126775 |
| authorships[4].affiliations[0].raw_affiliation_string | Vanda Pharmaceuticals, Inc, Washington, DC. |
| authorships[4].institutions[0].id | https://openalex.org/I4210126775 |
| authorships[4].institutions[0].ror | https://ror.org/0394qmm90 |
| authorships[4].institutions[0].type | company |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210126775 |
| authorships[4].institutions[0].country_code | US |
| authorships[4].institutions[0].display_name | Vanda Pharmaceuticals (United States) |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Sandra P Smieszek |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Vanda Pharmaceuticals, Inc, Washington, DC. |
| authorships[5].author.id | https://openalex.org/A5109033163 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Changfu Xiao |
| authorships[5].countries | US |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I4210126775 |
| authorships[5].affiliations[0].raw_affiliation_string | Vanda Pharmaceuticals, Inc, Washington, DC. |
| authorships[5].institutions[0].id | https://openalex.org/I4210126775 |
| authorships[5].institutions[0].ror | https://ror.org/0394qmm90 |
| authorships[5].institutions[0].type | company |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210126775 |
| authorships[5].institutions[0].country_code | US |
| authorships[5].institutions[0].display_name | Vanda Pharmaceuticals (United States) |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Changfu Xiao |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Vanda Pharmaceuticals, Inc, Washington, DC. |
| authorships[6].author.id | https://openalex.org/A5042907427 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-8920-8013 |
| authorships[6].author.display_name | Christos Polymeropoulos |
| authorships[6].countries | US |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4210126775 |
| authorships[6].affiliations[0].raw_affiliation_string | Vanda Pharmaceuticals, Inc, Washington, DC. |
| authorships[6].institutions[0].id | https://openalex.org/I4210126775 |
| authorships[6].institutions[0].ror | https://ror.org/0394qmm90 |
| authorships[6].institutions[0].type | company |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210126775 |
| authorships[6].institutions[0].country_code | US |
| authorships[6].institutions[0].display_name | Vanda Pharmaceuticals (United States) |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Christos M Polymeropoulos |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Vanda Pharmaceuticals, Inc, Washington, DC. |
| authorships[7].author.id | https://openalex.org/A5061765564 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | Gunther Birznieks |
| authorships[7].countries | US |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210126775 |
| authorships[7].affiliations[0].raw_affiliation_string | Vanda Pharmaceuticals, Inc, Washington, DC. |
| authorships[7].institutions[0].id | https://openalex.org/I4210126775 |
| authorships[7].institutions[0].ror | https://ror.org/0394qmm90 |
| authorships[7].institutions[0].type | company |
| authorships[7].institutions[0].lineage | https://openalex.org/I4210126775 |
| authorships[7].institutions[0].country_code | US |
| authorships[7].institutions[0].display_name | Vanda Pharmaceuticals (United States) |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Gunther Birznieks |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Vanda Pharmaceuticals, Inc, Washington, DC. |
| authorships[8].author.id | https://openalex.org/A5031674961 |
| authorships[8].author.orcid | https://orcid.org/0000-0001-5065-5353 |
| authorships[8].author.display_name | Mihael H. Polymeropoulos |
| authorships[8].countries | US |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I4210126775 |
| authorships[8].affiliations[0].raw_affiliation_string | Vanda Pharmaceuticals, Inc, Washington, DC. |
| authorships[8].institutions[0].id | https://openalex.org/I4210126775 |
| authorships[8].institutions[0].ror | https://ror.org/0394qmm90 |
| authorships[8].institutions[0].type | company |
| authorships[8].institutions[0].lineage | https://openalex.org/I4210126775 |
| authorships[8].institutions[0].country_code | US |
| authorships[8].institutions[0].display_name | Vanda Pharmaceuticals (United States) |
| authorships[8].author_position | last |
| authorships[8].raw_author_name | Mihael H Polymeropoulos |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Vanda Pharmaceuticals, Inc, Washington, DC. |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.psychiatrist.com/read-pdf/51087 |
| open_access.oa_status | bronze |
| open_access.any_repository_has_fulltext | False |
| created_date | 2024-01-13T00:00:00 |
| display_name | Efficacy and Safety of Iloperidone in Bipolar Mania |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10854 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9997000098228455 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2738 |
| primary_topic.subfield.display_name | Psychiatry and Mental health |
| primary_topic.display_name | Bipolar Disorder and Treatment |
| related_works | https://openalex.org/W2111561440, https://openalex.org/W2091339138, https://openalex.org/W2584235363, https://openalex.org/W4248440537, https://openalex.org/W2017910418, https://openalex.org/W2405140104, https://openalex.org/W2067790056, https://openalex.org/W3117801596, https://openalex.org/W2025288611, https://openalex.org/W1964989506 |
| cited_by_count | 6 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 5 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 1 |
| locations_count | 2 |
| best_oa_location.id | doi:10.4088/jcp.23m14966 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S17992710 |
| best_oa_location.source.issn | 0160-6689, 1534-8628, 1555-2101 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 0160-6689 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | The Journal of Clinical Psychiatry |
| best_oa_location.source.host_organization | https://openalex.org/P4322614534 |
| best_oa_location.source.host_organization_name | Physicians Postgraduate Press, Inc. |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4322614534 |
| best_oa_location.source.host_organization_lineage_names | Physicians Postgraduate Press, Inc. |
| best_oa_location.license | |
| best_oa_location.pdf_url | https://www.psychiatrist.com/read-pdf/51087 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | The Journal of Clinical Psychiatry |
| best_oa_location.landing_page_url | https://doi.org/10.4088/jcp.23m14966 |
| primary_location.id | doi:10.4088/jcp.23m14966 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S17992710 |
| primary_location.source.issn | 0160-6689, 1534-8628, 1555-2101 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0160-6689 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | The Journal of Clinical Psychiatry |
| primary_location.source.host_organization | https://openalex.org/P4322614534 |
| primary_location.source.host_organization_name | Physicians Postgraduate Press, Inc. |
| primary_location.source.host_organization_lineage | https://openalex.org/P4322614534 |
| primary_location.source.host_organization_lineage_names | Physicians Postgraduate Press, Inc. |
| primary_location.license | |
| primary_location.pdf_url | https://www.psychiatrist.com/read-pdf/51087 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | The Journal of Clinical Psychiatry |
| primary_location.landing_page_url | https://doi.org/10.4088/jcp.23m14966 |
| publication_date | 2024-01-12 |
| publication_year | 2024 |
| referenced_works | https://openalex.org/W3031499104, https://openalex.org/W2082795346, https://openalex.org/W2167659819, https://openalex.org/W6684309944, https://openalex.org/W3046616180, https://openalex.org/W2170684975, https://openalex.org/W1974127394, https://openalex.org/W1973413920, https://openalex.org/W2903942364, https://openalex.org/W2793422984, https://openalex.org/W2334399840, https://openalex.org/W3207791644, https://openalex.org/W2101903740, https://openalex.org/W2150049965, https://openalex.org/W3145255814, https://openalex.org/W2131823335, https://openalex.org/W1973852234, https://openalex.org/W2149988964, https://openalex.org/W1847851489, https://openalex.org/W2981352576, https://openalex.org/W2055615405, https://openalex.org/W4210998119, https://openalex.org/W2518626167, https://openalex.org/W1999689270, https://openalex.org/W2081878543, https://openalex.org/W2085168171, https://openalex.org/W2323832085, https://openalex.org/W2078075633, https://openalex.org/W2019465651, https://openalex.org/W4221110855, https://openalex.org/W2044954427, https://openalex.org/W2944335326, https://openalex.org/W2791988318, https://openalex.org/W3162259891, https://openalex.org/W2792027821, https://openalex.org/W2054835817, https://openalex.org/W2003816877, https://openalex.org/W3020440733, https://openalex.org/W2086095198, https://openalex.org/W2059616402, https://openalex.org/W2604483443, https://openalex.org/W2043369015, https://openalex.org/W2746379998, https://openalex.org/W2060003069, https://openalex.org/W1999544522, https://openalex.org/W2586571825, https://openalex.org/W3212865282, https://openalex.org/W2938863656, https://openalex.org/W2016079507, https://openalex.org/W1532689205, https://openalex.org/W2978677315, https://openalex.org/W2165379748, https://openalex.org/W2950375827, https://openalex.org/W3082424719, https://openalex.org/W4281687410 |
| referenced_works_count | 55 |
| abstract_inverted_index.EudraCT: | 5 |
| abstract_inverted_index.<b><i>Trial | 0 |
| abstract_inverted_index.identifier: | 3 |
| abstract_inverted_index.NCT04819776; | 4 |
| abstract_inverted_index.2020-000405-83. | 6 |
| abstract_inverted_index.ClinicalTrials.gov | 2 |
| abstract_inverted_index.Registration:</i></b> | 1 |
| cited_by_percentile_year.max | 98 |
| cited_by_percentile_year.min | 90 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 9 |
| citation_normalized_percentile.value | 0.91199424 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |